X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES TORRENT PHARMA ALKEM LABORATORIES/
TORRENT PHARMA
 
P/E (TTM) x - 26.7 - View Chart
P/BV x 6.3 6.5 95.7% View Chart
Dividend Yield % 0.7 3.1 22.7%  

Financials

 ALKEM LABORATORIES   TORRENT PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
TORRENT PHARMA
Mar-16
ALKEM LABORATORIES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5891,720 92.4%   
Low Rs1,2321,134 108.7%   
Sales per share (Unadj.) Rs417.5394.5 105.8%  
Earnings per share (Unadj.) Rs56.3101.8 55.3%  
Cash flow per share (Unadj.) Rs64.7116.3 55.6%  
Dividends per share (Unadj.) Rs12.7040.00 31.8%  
Dividend yield (eoy) %0.92.8 32.1%  
Book value per share (Unadj.) Rs292.9200.3 146.3%  
Shares outstanding (eoy) m119.57169.22 70.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.6 93.4%   
Avg P/E ratio x25.114.0 178.7%  
P/CF ratio (eoy) x21.812.3 177.7%  
Price / Book Value ratio x4.87.1 67.6%  
Dividend payout %22.639.3 57.4%   
Avg Mkt Cap Rs m168,653241,435 69.9%   
No. of employees `000NA10.9 0.0%   
Total wages/salary Rs m9,1718,559 107.2%   
Avg. sales/employee Rs ThNM6,129.6-  
Avg. wages/employee Rs ThNM785.8-  
Avg. net profit/employee Rs ThNM1,581.3-  
INCOME DATA
Net Sales Rs m49,91566,764 74.8%  
Other income Rs m1,6452,156 76.3%   
Total revenues Rs m51,56168,920 74.8%   
Gross profit Rs m8,48227,204 31.2%  
Depreciation Rs m1,0062,461 40.9%   
Interest Rs m6711,859 36.1%   
Profit before tax Rs m8,45125,041 33.7%   
Minority Interest Rs m-1140 37,933.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,403 0.0%   
Tax Rs m1,6066,414 25.0%   
Profit after tax Rs m6,73117,224 39.1%  
Gross profit margin %17.040.7 41.7%  
Effective tax rate %19.025.6 74.2%   
Net profit margin %13.525.8 52.3%  
BALANCE SHEET DATA
Current assets Rs m27,06246,622 58.0%   
Current liabilities Rs m15,32432,843 46.7%   
Net working cap to sales %23.520.6 113.9%  
Current ratio x1.81.4 124.4%  
Inventory Days Days6774 89.6%  
Debtors Days Days4179 52.2%  
Net fixed assets Rs m12,61039,029 32.3%   
Share capital Rs m239846 28.3%   
"Free" reserves Rs m34,49031,400 109.8%   
Net worth Rs m35,02733,890 103.4%   
Long term debt Rs m1,21218,637 6.5%   
Total assets Rs m54,38790,136 60.3%  
Interest coverage x13.614.5 94.0%   
Debt to equity ratio x00.5 6.3%  
Sales to assets ratio x0.90.7 123.9%   
Return on assets %13.621.2 64.3%  
Return on equity %19.250.8 37.8%  
Return on capital %24.948.5 51.2%  
Exports to sales %12.943.3 29.9%   
Imports to sales %3.16.9 44.9%   
Exports (fob) Rs m6,46128,934 22.3%   
Imports (cif) Rs m1,5404,584 33.6%   
Fx inflow Rs m6,56329,185 22.5%   
Fx outflow Rs m3,0126,021 50.0%   
Net fx Rs m3,55223,165 15.3%   
CASH FLOW
From Operations Rs m7,25927,132 26.8%  
From Investments Rs m1,864-7,014 -26.6%  
From Financial Activity Rs m-9,273-14,352 64.6%  
Net Cashflow Rs m-1505,767 -2.6%  

Share Holding

Indian Promoters % 66.9 71.5 93.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 7.0 471.5%  
FIIs % 0.0 12.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 8.8 -  
Shareholders   68,381 26,511 257.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  SUN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 17, 2017 01:50 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS